FindTrial
Sign In

Sulfur Hexafluoride Lipid Microspheres

DRUG7 trials

Sponsors

University of Southern California, M.D. Anderson Cancer Center, UNC Lineberger Comprehensive Cancer Center, john eisenbrey

Conditions

Breast CarcinomaCirrhosisHepatocellular CarcinomaKidney CancerKidney Disease, ChronicLiver NeoplasmsRecurrent Renal Cell CarcinomaRenal Cell Carcinoma

Early Phase 1

Contrast Enhanced Ultrasound With Lumason in Detecting Liver Cancer in Participants With Cirrhosis
CompletedNCT03407001
M.D. Anderson Cancer CenterCirrhosis
Start: 2018-01-12End: 2020-09-15Updated: 2020-10-14

Phase 1

Contrast Enhanced Ultrasound Medical Imaging for Identifying Breast Masses
RecruitingNCT06171607
University of Southern CaliforniaBreast Carcinoma
Start: 2020-11-05End: 2027-11-05Target: 100Updated: 2026-02-02

Phase 2

Contrast-enhanced Ultrasound as a Screening Tool for Kidney Cancer in Patients With Von-Hippel Lindau
CompletedNCT03907657
UNC Lineberger Comprehensive Cancer CenterKidney Disease, Chronic, Von-Hippel Lindau
Start: 2019-09-23End: 2023-03-13Updated: 2024-05-21
Contrast-Enhanced Ultrasound for Kidney Cancer Subtyping and Staging
CompletedNCT04021238
UNC Lineberger Comprehensive Cancer CenterKidney Cancer
Start: 2020-10-07End: 2022-08-05Updated: 2023-11-13
Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post Ablation
RecruitingNCT05641935
john eisenbreyRecurrent Renal Cell Carcinoma, Renal Cell Carcinoma
Start: 2022-11-03End: 2027-08-31Target: 210Updated: 2026-02-17
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
RecruitingNCT06261814
john eisenbreyLiver Neoplasms
Start: 2024-08-07End: 2028-01-01Target: 266Updated: 2026-02-17

Unknown Phase

Contrast-Enhanced Ultrasound in Diagnosing Patients With Liver Cancer Undergoing Yttrium-90 Radioembolization
WithdrawnNCT03300401
University of Southern CaliforniaHepatocellular Carcinoma
Start: 2017-11-07End: 2020-11-07Updated: 2019-05-16